Divergent immunobiological correlates of FDA-/EMA-approved PD-L1 assays and scoring algorithms in muscle-invasive bladder cancer - Weyerer, V; Geppert, CI; Bertz, S; Taubert, H; Breyer, J; Bolenz, C; Erben, P; Wach, S; Sikic, D; Kunath, F; Wullich, B; Hartmann, A; et al. (Urologic oncology, 2020)